Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SIGA TechnologiesSIGA +1.86%60 Net Margin % is 30.40% as of Jun. 2026, which is 17% below its 10-year median of 36.65. GuruFocus rates SIGA with a GF Score™ of 60/100 and a GF Value™ of $2.55 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 960 Drug Manufacturers companies, SIGA Technologies ranks worse than 71.35% on this metric.
SIGA Technologies (NAS:SIGA) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
SIGA Technologies Net Margin % Related Terms
SIGA Technologies Net Margin % Historical Data
* Premium members only.
The historical data trend for SIGA Technologies's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, SIGA Technologies's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SIGA Technologies Net Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, SIGA Technologies's Net Margin % distribution charts can be found below:
* The bar in red indicates where SIGA Technologies's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SIGA Technologies (SIGA) has a Net Margin % of 30.40% as of Jun. 2026. Net margin is the ratio of total net income to net sales. View historical data on SIGA Technologies and its competitors. This is 17% below median its historical median of 36.65. According to the industry distribution chart, SIGA Technologies ranks #685 out of 960 companies in the Drug Manufacturers industry, placing it in the top 71.4%.
Is SIGA Technologies' Net Margin % too high?
SIGA Technologies' current Net Margin % of 30.40% is 17% below median its 10-year median of 36.65. The Drug Manufacturers industry median Net Margin % is 5.21. SIGA Technologies' value of 30.40% is 484.1% above this industry median. Based on the distribution chart, SIGA Technologies ranks #685 out of 960 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, SIGA Technologies has a GF Score™ of 60/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does SIGA Technologies' Net Margin % compare to ORGO and DERM?
According to the Drug Manufacturers industry distribution chart, SIGA Technologies ranks #685 out of 960 companies for Net Margin %. This places SIGA Technologies in the lower half of its industry. The industry median Net Margin % is 5.21. SIGA Technologies' value of 30.40% is 484.1% above this benchmark. While the company's 10-year median is 36.65 vs. the industry median of 5.21, SIGA Technologies has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.21, based on 960 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SIGA Technologies's current Net Margin % of 30.40% is 484.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on SIGA Technologies and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SIGA Technologies's current Net Margin % is 30.40%, which is 17% below median its own 10-year median of 36.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SIGA Technologies stock overvalued right now?
Based on GuruFocus' analysis, SIGA Technologies (SIGA) is currently considered Modestly Overvalued. The stock's GF Value™ is $2.55, compared to a current price of $3.29 — trading 29% above its estimated fair value. The current Net Margin % is 30.40%, which is 17% below median its 10-year median of 36.65 and 484.1% above the Drug Manufacturers industry median of 5.21. SIGA Technologies' overall GF Score™ is 60/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For SIGA Technologies (SIGA), the current Net Margin % is 30.40% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SIGA Technologies (SIGA) Overvalued in 2026?
Based on GuruFocus' analysis, SIGA Technologies stock appears to be overvalued.
The current stock price of $3.29 is trading 29% above its estimated GF Value™ of $2.55.
GuruFocus considers SIGA Technologies to be Modestly Overvalued.
Key valuation signals for SIGA:
Net Margin %: 30.40% (17% below median its 10-year median of 36.65)
GF Value™: $2.55 vs. price of $3.29 (29% above fair value)
Industry Position: 484.1% above the Drug Manufacturers median (#685 of 960)
No single metric tells the full story. See the SIGA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SIGA Technologies Inc a commercial-stage pharmaceutical company. The Company sells its product, TPOX oral TPOXX, also known as tecovirimat, Tecovirimat-SIGA, or TEPOXX (tecovirimat) in certain international markets, to the U.S. Government and international governments (including government-affiliated entities). The Company operates in one single operating and reportable segment, which includes all activities related to the sale of the Company's Oral and IV TPOXX as well as research and development services.
60GF Score
Get the complete analysis for SIGA
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SIGA has been successfully added to your 
